24/7 Customer Support
Global Mechanical Ventilator Market was valued at US$ 4,772.8 million in 2023 and is estimated to generate a revenue of US$ 9,668.8 million by 2032 at a CAGR of 8.16% during the forecast period 2024-2032
Multipurpose, but essential. Mechanical ventilators are the backbone of healthcare. They’re vital in making sure patients who can’t breathe are supported with external ease. Wherein, diseases like COPD and ARDS make it hard for patients to breathe on their own so these machines do it for them. In an ICU, they come in handy when a patient is in critical condition. Patients with respiratory failure suffer from different diseases like pneumonia and infectious diseases such as COVID-19 that require them to be on a ventilator. COPD, pneumonia, ARDS all contribute heavily to the need and demand for mechanical ventilators. What’s worse is that their prevalence is increasing. The onset of COVID-19 made matters even worse exponentially increasing demand as a significant number of cases turned into ARDS cases which meant they needed to be on a machine or support their breathing.
In the past 5 years, the global mechanical ventilator market has witnessed a significant change in the affordability of the mechanical ventilators. Their prices vary depending on the brand, size, and features included. However, their average price ranges anywhere from $2000–$50,000. This variability reflects the range of technologies incorporated into ventilators, from basic models used in emergency situations and transport to sophisticated units capable of providing a variety of ventilatory modes in intensive care settings.
As soon as COVID hit, everyone was rushing around trying to find a way to produce more ventilators quicker — while still keeping that quality assurance in mind — so there wouldn't be any shortages globally. Emergency departments use most of these devices followed by long-term care facilities then by hospitals. Some patients may just need oxygen in their lungs others need carbon dioxide removed from their body so having something when your lungs are damaged is also crucial because if not it could cause some serious damage.
To Get more Insights, Request A Free Sample
Aging Populations: A Powerful Driver for Mechanical Ventilator Demand
The demographic shift toward a global population that is increasingly aged will be a key driver of the mechanical ventilator market. As people age, the prevalence of respiratory disorders and need for critical care interventions such as mechanical ventilation rise significantly. This trend can be illustrated with some figures: The World Health Organization reports that by 2050 there will be around 2 billion people in the world aged 60 years and older, compared to just 900 million in 2015. Furthermore, over four million deaths occur each year worldwide due to chronic respiratory diseases occurring more frequently in older patients. Finally, over 251 million cases of COPD are present globally according to the Global Burden of Disease Study which is another indication of rising demand for ventilatory support. The COVID-19 pandemic has only increased awareness on how susceptible elderly individuals are when it comes to respiratory infections; this resulted in a surge of mechanical ventilators being used. Hospitals have seen an influx of ICU admissions for respiratory issues and mechanical ventilation is a core part of treatment during these cases. Considered alongside long-lasting healthcare obstacles like chronic respiratory diseases and pandemics, aging quickly becomes clear as a central driver in the growth seen by the market.
Telehealth Integration: Revolutionizing Mechanical Ventilation Management
Telehealth integration is seen by many as an innovative avenue in terms of mechanical ventilation management within the industry as well as worldwide. By combining both aspects health providers hope to enhance patient care, optimize resource allocation and improve overall outcomes for those needing any kind of ventilatory support. In recent years hospitals have been opening up more to the technology—according to statistics released by the American Hospital Association almost 8 out every 10 hospitals now connect patients with consulting practitioners through video or other technologies; this number marks significant growth from previous years. When looked at telehealth-enabled mechanical ventilators, it is noticed that they facilitate remote monitoring; doing so allows healthcare providers to constantly assess patient status along with how well their respective ventilators are functioning—a feature that was vital when dealing with COVID-19. These numbers are further supported by studies showing that patients with respiratory illnesses had hospital readmission rates decrease by as much as 20% when telehealth services were used. The technology doesn’t stop there though, it also makes personalized ventilation management possible which adapts to a patient's needs dynamically and has even been shown to cut down the length of ICU stays in some cases. Given that the global telehealth market is expected to reach $266.8 billion by 2026, this new trend is definitely worth watching.
Supply Chain Volatility: A Restraint on Mechanical Ventilator Accessibility
In the global market for mechanical ventilators, supply chain volatility is an unwelcome burden. It causes availability issues and late deliveries that hinders the medical device's purpose. During the COVID-19 pandemic, we saw just how vulnerable global supply chains were. With an unprecedented spike in demand for mechanical ventilators came shortages and new logistical challenges. At its peak, there was a threefold increase in demand for these machines, which suppliers couldn’t meet due to capacity issues. Making matters worse was that suppliers often relied on a small number of components that were sourced from specific areas around the world. This meant if just one component was missing it could stop thousands of ventilators from going into production in the mechanical ventilator market. There was also a report from the World Trade Organization where they stated trade barriers had significant impacts on medical goods’ free flow — including ventilators — during the pandemic. Long story short, we need more resilient supply chains and manufacturing strategies so we’re better prepared in times of crisis like this. For now, though, companies must quickly adapt to navigate through these complexities to make sure everyone has access to their own machine when needed.
Positive pressure ventilation — the most common type of mechanical ventilators — makes up over 63% of the total market. The reason for its reign is its capability to treat a variety of respiratory conditions. From acute respiratory distress syndrome (ARDS) to chronic obstructive pulmonary disease (COPD), positive pressure ventilation can do it all. For people who can’t get enough air on their own, this technology ensures they still receive the oxygen they need via an active push into their lungs. These facts couple with its expected growth rate of around 8.31%, made possible by improved patient comfort from technological advancements and better outcomes, solidifies its power position.
The non-invasive segment dominates the mechanical ventilator market with a 57% share due to benefits like reduced risk of infections, increased patient comfort and shorter hospital stays. Ventilation without any kind of intubation allows for management in acute and chronic cases while avoiding invasive methods. Sleep apnea, COPD and COVID-19 have also contributed to this method's growth at a CAGR of 8.28%. And as long as there’s innovation that offers more advanced monitoring capabilities along with customizable modes, NIV will keep growing.
Fixed systems held onto their majority share in the mobility category at 57%, but portable devices are coming in hot with an expected CAGR of 8.39% in the global mechanical ventilator market. ICU settings rely heavily on fixed machines because they’re capable of providing comprehensive ventilation capabilities for patients in critical condition. However, portable options are taking over because they make it possible to take care outside traditional hospitals thanks to improved technology that no longer hinders functionality for transportability.
By End Users
Hospitals and clinics take up about 45% market share and play essential roles in emergency, perioperative and intensive care moments in the global mechanical ventilator market. Hospitals aren’t going anywhere as global hospitalization rates rise due to respiratory diseases along with surgical procedures that require postoperative ventilatory support. In addition, the global expansion of hospital infrastructure will only help it grow. Lastly, COVID-19 brought on a spike in demand for ventilators in hospitals and clinics, as well as an overall need for better critical care capabilities. As the population ages and healthcare facilities advance, so too will this field.
By Age Group
Adults currently have a massive grip on the global mechanical ventilator market, with over 43% share. This is due to Adults and the Elderly’s high susceptibility to catching respiratory diseases. However, it’s projected that the segment for pediatric and neonatal will grow at an extremely fast pace. With a CAGR of 8.5%. The reason behind this is because there are more initiatives focused on children and newborn care. Plus, improvements in technologies used towards this purpose are making waves too. New innovations made to minimize potential lung damage cause by ventilators for kids and newborns while also being able to reduce infant mortality rates around the globe are causing so much momentum with this segment.
To Understand More About this Research: Request A Free Sample
In North America, especially in the United States (US) and Canada, the mechanical ventilator market is the biggest. The region controlled over 46% of the global market share. North America’s dominance can be attributed to several factors including an advanced healthcare infrastructure, high healthcare expenditure, and a robust presence of leading ventilator manufacturers. The US for example has invested heavily in its healthcare industry which accounts for about 16.9% of its GDP providing favorable conditions for adoption of advanced medical technologies. The markets in these areas are also driven by a strong emphasis on research and development leading to new innovations in Ventilator technology.
North American countries have also been plagued by respiratory diseases such as chronic obstructive pulmonary disease (COPD), which affected over 16 million Americans; and COVID-19 that infected over 28 million people in the US alone. This led to a rise in demand for mechanical ventilators. To keep up with this increasing demand, eview processes were sped up so that medical devices could be deployed more easily while also ensuring that they complied with regulatory measures put forward by the governments.
The Asia Pacific mechanical ventilator market which includes countries like India, China, Japan, Australia and South Korea is projected to have the highest growth rate In recent years due to escalating healthcare infrastructure development, increasing healthcare spending, rising burden of respiratory diseases China and India — with their vast populations — have seen an increase in the prevalence of respiratory conditions; China already has more than 100 million chronic respiratory disease patients. Japan was one of the first countries outside of China to experience cases related to COVID-19 when a group of tourists tested positive on Jan. 16 last year after returning from Wuhan — where the virus originated). These trends are expected cause Asia Pacific’ health care expenditure which is already projected to increase significantly hit $1.5 trillion by 2025 captivating evidence that shows that China is focusing more on healthcare. China is also spearheading the region’s shift towards manufacturing medical devices, a move that reduces dependency on imports and fosters self-sufficiency; especially since it is one of the largest manufacturers in the world.
List of Key Companies Profiled:
Market Segmentation Overview:
By Age Group
By End User
|Market Size Value in 2023
|US$ 4,772.8 Mn
|Expected Revenue in 2032
|US$ 9,668.8 Mn
|Value (USD Mn)
|By Component, By Type, By Mode, By Mobility, By Age Group, By End User, By Region
|Becton, Dickinson and Company, Bunnell Incorporated, Carl Reiner GmbH, Drägerwerk AG & Co. KGaA, GE Healthcare, Getinge AB, Hamilton Medical, ICU Medical, Inc, Koninklijke Philips N.V., Medtronic, Mindray Medical International Limited, Penlon Limited, ResMed, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Smiths Medical, Vyaire Medical Inc., Zoll Medical Corporation, Other prominent players
|Get your customized report as per your preference. Ask for customization
LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.SPEAK TO AN ANALYST